KernDG, FrumkinH.Asthma in respiratory therapists. Ann Intern Med1989;110:767–773.
2.
CharneyW, CorkeryKJ, KraemerR, WugofskiL.Engineering and administrative controls to contain aerosolized ribavirin: results of simulation and application to one patient. Respir Care1990;35:1042–1047.
3.
WaskinH.Toxicology of antimicrobial aerosols: a review of aerosolized ribavirin and pentamidine. Respir Care1991;36:1026–1036.
4.
FallatRJ, KandalK, FeigalD.Pentamidine aerosol (PA) to prevent pneumocystis pneumonia (PCP) (abstract). Am Rev Respir Dis1988;137(4, Part 2):120.
5.
LeoungGS, FeigalDWJr, MontgomeryAB, CorkeryK, WardlawL, AdamsM, . Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia: the San Francisco community prophylaxis trial. N Engl J Med1990;323:769–775.
6.
CorkeryKJ, LuceJM, MontgomeryAB. Aerosolized pentamidine for treatment and prophylaxis of Pneumocystis carinii pneumonia: an update. Respir Care1988;33:676–685.
7.
MontgomeryAB, DebsRJ, LuceJM, CorkeryKJ, TurnerJ, BrunetteEN, . Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet1987;2:480–483.
8.
MontgomeryAB, DebsRJ, LuceJM, CorkeryKJ, TurnerJ, BrunetteEN, . Selective delivery of pentamidine to the lung by aerosol. Am Rev Respir Dis1988;137:477–478.
CorkeryKJ, MontgomeryAB, MontantiR, FineJM. Airway effects of aerosolized pentamidine isethionate (abstract). Am Rev Respir Dis1990;141(4, Part 2):A152.
11.
DebsR, BrunetteE, FuchsH, LinE, ShahM, HargisA, . Biodistribution, tissue reaction, and lung retention of pentamidine aerosolized as three different salts. Am Rev Respir Dis1990;142:1164–1167.
12.
LoweryS, FallatRJ, MontgomeryAB, BergeJ.Changing patterns of Pneumocystis carinii pneumonia on pentamidine aerosol prophylaxis. Abstract from IV International Conference on AIDS, Stockholm, 1988.
13.
WardlawLA, MontgomeryAB, CorkeryKJ, AbramsDI, FeigalDW, LeoungGS. Pneumothorax in patients receiving aerosol pentamidine prophylaxis for Pneumocystis carinii pneumonia (abstract). Am Rev Respir Dis1990;141(4, Part 2):A152.
14.
GudeJK. Selective delivery of pentamidine to the lung by aerosol (letter). Am Rev Respir Dis1989;139:1060.
15.
GhediraH, RegnardJ, DessangesJF, LockhartA, MarsacJ, LacroniqueJ.Chronic cough and bronchial hyperresponsiveness in AIDS patients treated with aerosolized pentamidine (abstract). Am Rev Respir Dis1990;141(4, Part 2):A151.
16.
BalmesJR. Propellant gases in metered dose inhalers: their impact on the global environment. Respir Care1991;36:1037–1044.
17.
SmaldoneGC, FuhrerJ, SteigbigelRT. Quantitative deposition of aerosolized pentamidine in AIDS (abstract). Am Rev Respir Dis1990;141(4, Part 2):A150.
18.
VinciguerraC, SmaldoneG.Treatment time and patient tolerance for pentamidine delivery by Respirgard II and AeroTech II. Respir Care1990;35:1037–1041.
19.
DautzenbergB, MeignanM, BouchikhiA, AntounF, BragaMRoyF, BecqueminMH, . Comparison of 5 devices for pentamidine aerosol administration (abstract). Am Rev Respir Dis1990;141(4, Part 2):A153.
20.
IlowiteJS, GorvoyJD, SmaldoneGC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis1987;136:1445–1449.
21.
IlowiteJS, BaskinMI, SheetzMS, AbdAG. Comparison of delivered dose and regional distribution of aerosolized pentamidine using different delivery systems (abstract). Am Rev Respir Dis1990;141(4, Part 2):A153.
NardellEA, KeeganJ, CheneySA, EtkindSC. Airborne infection: the theoretical limits of protection achievable by building ventilation. Am Rev Respir Dis (in press) 1991.
24.
Centers for Disease Control. Tuberculosis and acquired immunodeficiency syndrome, New York City. MMWR1987;36:785–795.
25.
Guidelines for construction and equipment of hospital and medical facilities, 1984. Rockville MD: U.S. Dept of Health and Human Services, Health Resources and Services Administration, Publication No. (HRSA) 84-14500.
26.
The American Society of Heating, Refrigerating, and Air Conditioning Engineers (ASHRAE). Ventilation for acceptable indoor air quality. Standard 62. Atlanta: ASHRAE, 1989.
27.
RileyRL. The hazard is relative. Am Rev Respir Dis1967;96:623–635.
28.
RileyRL, NardellEA. Clearing the air: the theory and application of ultraviolet air disinfection. Am Rev Respir Dis1989;139:1286–1294.
29.
CantazaroA.Nosocomial tuberculosis. Am Rev Respir Dis1982;125:559–562.
30.
WellsWF, WellsMW, WilderTS. The environmental control of epidemic contagion. I. An epidemiologic study of radiant disinfection of air in day schools. Am J Hygiene1942;35:97–121.
31.
RileyRL, MillsCC, O'GradyF, SultanLU, WittestadtF, ShivpuriDN. Infectiousness of air from a tuberculosis ward: ultraviolet irradiation of infected air; comparative infectiousness of different patients. Am Rev Respir Dis1962;85:511–525.
32.
Council on Scientific Affairs, American Medical Association (AMA). Harmful effects of ultraviolet radiation. Chicago: AMA, 1984.
33.
Ha'eriGB, WileyAM. The efficacy of standard surgical face masks: an investigation using "tracer particles."Clin Orthop1980;148:160–162.
34.
TuomiT.Face seal leakage of half masks and surgical masks. Am Ind Hyg Assoc J1985;46:308–312.
35.
ChenCC, RuuskanenJ, PilacinskiW, WillekeK.Filter and leak penetration characteristics of a dust and mist filtering facepiece. Am Ind Hyg Assoc J1990;51:632–639.
36.
RogersKB. An investigation into the efficacy of disposable face masks. J Clin Pathol1980;33:1086–1091.
37.
Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR1990;39(RR-17):1–29.
